NCT05797246 2026-01-26
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institute of Allergy and Infectious Diseases (NIAID)